ITM Secures Up to $262.5M in Non-Dilutive Debt Financing with Blue Owl Managed Funds

Blue Owl Capital Invests up to $262.5 Million in ITM Isotope Technologies Munich SE // Cooley // Global Law Firm

ITM reveals up to $262M debt financing; Caris Life Sciences to go public

Plus, news about Lexeo, TreeFrog Therapeutics, Hansa Biopharma, AbbVie, Elpiscience Biopharmaceuticals, Immutep, Hedera Dx, C4X Discovery, Sanofi, XOMA and BioInvent: ITM Isotope Technologies Munich gets $262.5M from Blue Owl Capital: The radiopharmaceuticals company plans to ...

ITM Secures Up to $262.5M in Non-Dilutive Debt Financing with Blue Owl Managed Funds

ITM Isotope Technologies Munich SE, a Garching, Germany-based radiopharmaceutical biotech company, announced a debt financing agreement for up to $262.5M from funds managed by Blue Owl Capital. The capital will be used to prepare for commercial readiness and potential market launch of the company’s lead candidate, n.c.a. 177Lu-edotreotide (also known as ITM-11 or 177Lu-edotreotide). Led by CEO Dr. […] The post ITM Secures Up to $262.5M in Non-Di…